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Summary: Interference occurs between individuals when the treatment (or exposure) of one individual affects
the outcome of another individual. Previous work on causal inference methods in the presence of interference has
focused on the setting where a priori it is assumed there is ‘partial interference,’ in the sense that individuals
can be partitioned into groups wherein there is no interference between individuals in different groups. Bowers,
Fredrickson, and Panagopoulos (2012) and Bowers, Fredrickson, and Aronow (2016) consider randomization-based
inferential methods that allow for more general interference structures in the context of randomized experiments. In
this paper, extensions of Bowers et al. which allow for failure time outcomes subject to right censoring are proposed.
Permitting right censored outcomes is challenging because standard randomization-based tests of the null hypothesis
of no treatment effect assume that whether an individual is censored does not depend on treatment. The proposed
extension of Bowers et al. to allow for censoring entails adapting the method of Wang, Lagakos, and Gray (2010)
for two sample survival comparisons in the presence of unequal censoring. The methods are examined via simulation
studies and utilized to assess the effects of cholera vaccination in an individually-randomized trial of 73, 000 children
and women in Matlab, Bangladesh.
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1. Introduction
Interference arises when an individual’s potential outcomes depend on the treatment status
of others. Assuming interference is absent when assessing the causal effect of a treatment on
an outcome may be scientifically implausible in certain settings. For example, in the study
of infectious diseases, whether one individual receives a vaccine may affect whether another
individual becomes infected or develops the disease. Motivated by infectious diseases and
other settings where individuals interact, many existing causal inference methods have been
extended to allow for interference; see Halloran and Hudgens (2016) for a recent review.
Some previous work on causal inference methods in the presence of interference has as-
sumed a priori that there is partial interference (Sobel, 2006), that is, individuals can be
partitioned into groups wherein there is no interference between individuals in different
groups. In this paper we consider the more general setting where interference between
any two individuals may be assumed. Recent approaches that allow for the presence of
general interference when evaluating treatment effects include Bowers, Fredrickson, and
Panagopoulos (2012), Bowers, Fredrickson, and Aronow (2016), Sussman and Airoldi (2017)
and Athey, Eckles, and Imbens (2018) among others. In randomized experiments where the
treatment assignment mechanism is known, Bowers, Fredrickson, and Panagopoulos (2012)
(henceforth BFP) described how to carry out randomization-based (i.e., permutation or
design-based) inference on parameters in causal models which allow for general interference.
For an assumed causal model, a randomization-based approach entails constructing con-
fidence sets for the causal parameters by inverting a set of hypothesis tests. An appealing
aspect of randomization-based inference (Rosenbaum, 2002, Chapter 2) is that no assumption
of random sampling from some hypothetical superpopulation is invoked. Another benefit is
the resulting 100(1 − α)% confidence sets are exact, i.e., the probability the true causal
parameters are contained in a confidence set is at least the nominal level 1 − α. Moreover,
2in settings where possible interference is a priori assumed to have a specified network
structure, it is unreasonable to assume individual outcomes are independent, such that
standard frequentist approaches are not justified; in contrast randomization-based methods
that allow for possible general interference readily apply.
In this article, we propose extensions of Bowers et al. to the setting where the response of in-
terest is a failure time, and only the censoring time is observed for a subset of individuals due
to right censoring. In general, when there is right censoring randomization-based inference
on the failure times is exact only when treatment does not affect the censoring times. The
proposal to permit right censored observations thus entails adapting the method of Wang,
Lagakos, and Gray (2010) for two sample survival comparisons in the presence of unequal
censoring. The remainder of this article is as follows. In Section 2 notation is introduced,
causal models are defined, and the randomization inferential procedure by Bowers et al.
when there is no censoring is reviewed. In Section 3 the proposed extension allowing for
right censored outcomes is presented, and simulation study results are shown demonstrating
the method approximately preserves the nominal size over a range of settings. In Section 4 the
methods are utilized to assess the effects of cholera vaccination in an individually-randomized
trial of n = 73, 000 women and children in Matlab, Bangladesh. A brief discussion is provided
in Section 5.
2. General Interference and Causal Models
2.1 General Interference
Consider a finite population of n individuals randomly assigned to either treatment or control.
For each individual i = 1, . . . , n, let Zi = 1 if individual i is assigned treatment and Zi = 0
otherwise. The vector comprising all treatment assignments is denoted Z = (Z1, . . . , Zn).
The uppercase Z denotes the random variable corresponding to treatment assignment and
the lowercase z denotes possible realizations of Z. Let yi(z) denote the potential outcome
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for individual i that would be observed for treatment assignment z; the observed outcome is
denoted by Yi = yi(Z). Let y(z)=(y1(z), . . . , yn(z)) denote the vector of potential outcomes.
The potential outcomes y(z) and z ∈ {0, 1}n are considered fixed features of the finite
population of n individuals.
Define the n×n interference matrix A with (i, j) entry Aij for i, j ∈ {1, . . . , n} as follows.
Let Aij = 0 for i = j. For i 6= j let Aij = 0 if it is assumed a priori individual j does not
interfere with individual i; otherwise let Aij = 1. Note that Aij = 0 implies it is assumed
a priori yi(z) does not depend on zj, whereas Aij = 1 merely indicates the possibility that
individual j may interfere with individual i, and does not necessarily imply yi(z) depends
on zj. Indeed, one of our primary inferential goals is to determine whether such possible
interference is present. The definition of A encodes the assumption that any spillover effects
on individual i may emanate only from individuals j where Aij = 1, and not from those
where Aij = 0. The exact relationship between yi(z) and z is specified using a causal model
described in the next section. Let the interference set (i.e., neighbors) for individual i be
the set of individuals j ∈ {1, . . . , n} \ i where Aij = 1. Denote the i-th row of A by
the vector Ai, and the size of the interference set by the scalar Ai =
∑n
j=1Aij. Under
partial interference, individuals can be partitioned into groups or clusters wherein there is
no interference between groups, in which case A can be expressed as a block-diagonal matrix
with each block corresponding to a group. Under general interference, each individual is
allowed to have their own possibly unique interference set, so that there is no restriction on
the structure of A. Here and throughout A is assumed known and invariant to treatment.
2.2 Causal Models
A (counterfactual) causal model expresses the potential outcomes yi(z) as a parametric
deterministic function of any treatment z. Following Bowers et al., we consider a class of
causal models which entail the composition of two functions. In particular, assume yi(z) =
4h{yi(0)|F(z; θ,A)} for user-specified functions h and F , with yi(0) denoting the potential
outcome under the uniformity trial (Rosenbaum, 2007) where no one receives treatment. The
function F(z; θ,A) takes as its arguments the treatment vector z, causal parameter θ, and
interference matrix A. The dependence of F(z; θ,A) on i is left implicit notationally as it
is implied under the specified causal model. For notational simplicity we write F = F(z; θ),
with the dependence on A implicit. The specification of F determines how an individual’s
potential outcomes differ across different treatments z and different values of the parameter
θ, and includes, but is not limited to, how direct and spillover effects propagate. The link
function h is a one-to-one function mapping yi(0) to yi(z) for a specified F ; in particular,
the uniformity trial potential outcomes can be determined from the observed data under a
specified causal model by yi(0) = h
−1 {Yi|F(Z; θ)}, where h−1 is the inverse of h(a|b).
In practice, prior beliefs or background knowledge may be used to inform the choice of
F and h. We consider two specific causal models, defined in (1) and (2) below, and assume
h(a|b) = a exp(b), although the proposed methods are general and apply to other forms of F
and h. Denote the number and proportion of individual i’s neighbors assigned to treatment
by Ti = AiZ
T and Gi = Ti/Ai respectively; here Ai = 0 implies Ti = Gi = 0. Note that Ti
and Gi depend on Z, but this dependence is suppressed for notational convenience. Let:
Fadd(Z; δ, τ) = δZi + τGi; (1)
FBFP(Z; δ, τ) = δ + log
[
1 + (1− Zi){exp(−δ)− 1} exp(−τ 2Ti)
]
. (2)
Under both causal models, the effect of treatment Z on the outcome for individual i takes the
form of a bivariate treatment: Zi is the (individual) treatment received, and Gi (or Ti) is the
proportion (or number) of individuals in the interference set treated. The parameters δ and
τ measure the extent to which the potential outcomes increase or decrease, relative to yi(0),
due to Zi and Gi (or Ti). Causal model (2) was proposed by BFP and restricts interference
to those who did not receive treatment, with the direct (or individual) effect parametrized
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to be larger in magnitude than the spillover (or peer) effect. As both Gi and Ti depend only
on the total number in the interference set treated, a peer effect homogeneity assumption is
implied by these two causal models; Hudgens and Halloran (2008) refer to the assumption
as stratified interference. Causal models allowing for interference that does not occur via
the summary Ti can also be utilized within this framework. For example, we might posit
F = δZi + τZMi where Mi = argmaxj:Aij=1Aj denotes the neighbor of individual i having
the biggest interference set. See Ogburn et al. (2017) and Sussman and Airoldi (2017) for
other causal models that allow for interference. The next section describes how to carry out
randomization inference for the parameter θ = (δ, τ) under a specified F .
2.3 Randomization inference
For a specified causal model F , the uniformity trial potential outcomes under a null hypoth-
esis H0 : θ = θ0 can be determined from the observed data by yi(0) = Yi exp {−F(Z; θ0)}. In
a randomized experiment where individuals are assigned treatment with equal probability,
the uniformity trial outcomes should be similarly distributed between treatment (Z = 1) and
control (Z = 0) groups (Rosenbaum, 2002) ifH0 is true and F is correctly specified. Therefore
the null hypothesis H0 can be tested using a test statistic T S(Z; θ0) that compares the
uniformity outcomes between treated and untreated individuals. For example, BFP used the
two-sample Kolmogorov-Smirnov (KS) test statistic to compare the empirical distributions
of the uniformity outcomes in the treatment and control groups. Bowers, Fredrickson, and
Aronow (2016) proposed a multiple linear regression model of the uniformity outcomes on
Z and T , using the resulting sum of squares of residuals as a test statistic.
For a chosen test statistic T S(Z; θ0), the plausibility of H0 can be assessed by evalu-
ating the frequency of obtaining a value at least as ‘extreme’ (from H0) as the observed
value, over hypothetical re-assignments of Z under H0. Here and throughout a completely
randomized experiment is assumed, where the number assigned to treatment, denoted by
6m =
∑n
i=1 Zi, is fixed by design. The sample space of all hypothetical re-assignments
Z is the set of vectors of length n containing m 1’s and n − m 0’s, and is denoted by
Ω = {z : zi ∈ {0, 1}, i = 1, . . . , n,
∑n
i=1 zi = m} . Each re-assignment occurs with probability
|Ω|−1, so that a two-sided p-value may be defined as pv(θ0)= |Ω|−1
∑
z∈Ω
I {T S(z;θ0)>T S(Z;θ0)},
where without loss of generality it is assumed the larger values of T S(Z; θ0) suggest stronger
evidence against H0, and I{B} = 1 if B is true and 0 otherwise. When it is not computa-
tionally feasible to enumerate Ω exactly, an approximation of Ω based on C random draws
of z from Ω may be used to yield an approximate p-value, denoted by pvC(θ0).
Confidence sets can be constructed by test inversion. The subset of θ0 values where pv(θ0),
or pvC(θ0), is greater than or equal to α forms a 100(1−α)% exact confidence set for θ.
Confidence sets for individual parameters in θ can be obtained readily from a confidence set
for θ. For example, a 100(1−α)% confidence set for δ is given by all values of δ0 such that
there exists some value of τ0 where (δ0, τ0) is in the 100(1−α)% confidence set for (δ, τ).
It is important to note that each hypothesis test assesses the compatibility of the observed
data with the assumed causal model F and assumed parameter values θ0 specified by F
under the null. Rejection of the hypothesis only indicates that either F or θ0 is implausible.
In some circumstances all feasible parameter values for an assumed causal model may be
rejected, leading to an empty confidence set. This indicates all possible parameter values are
implausible, implying that the assumed causal model provides a poor fit to the data.
3. Right censored failure time outcomes
Now suppose each individual’s outcome is a (positive) failure time, subject to right censoring
if the individual is not followed long enough for failure to be observed. For i = 1, . . . , n, let
Y˜i and Ci denote the failure time and the censoring time respectively. The failure time Y˜i
is observed only if Y˜i 6 Ci, so that the observed data are Yi = min{Y˜i, Ci} and the failure
indicator Di = I{Y˜i 6 Ci}. The outcomes being right censored causes two complications for
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the randomization inference approach described in Section 2. First, the test statistic employed
needs to account for right censoring; some possible statistics are discussed in Section 3.1.
Second, the null hypothesisH0 : θ = θ0 for a specified causal model F is no longer sharp in the
sense that not all uniformity trial potential outcomes can be determined from the observed
data under H0. To see this, define yi(0) = Yi exp {−F(Z; θ0)}, which can be determined
from the observed data as in the previous section. Let y˜i(0) = Y˜i exp {−F(Z; θ0)} denote the
uniformity trial potential failure time for individual i under H0. For individuals who are not
censored, Yi = Y˜i implies yi(0) = y˜i(0), i.e., the uniformity trial potential failure time can be
determined exactly under H0 if Di = 1. But for individuals who are censored, Y˜i is unobserved
so that y˜i(0) is unknown under H0. Nonetheless, it is known for these individuals that Yi < Y˜i;
multiplying both sides of this inequality by exp {−F(Z; θ0)}, it follows that yi(0) < y˜i(0).
Thus the observed censoring times provide some information about the unknown failure
times y˜i(0) for right censored individuals. In particular, yi(0) serves as a lower bound for
y˜i(0) under H0. Because the null hypothesis is no longer sharp, the randomization testing
approach in Section 2.3 in the absence of censoring requires modification; the proposed
approach is described in Section 3.2.
3.1 Test statistics that accommodate right censoring
The test statistics considered in Section 2.3 require modification to accommodate right
censoring. Instead of the KS statistic, the log-rank (LogR) statistic may be used to compare
the right censored uniformity failure times in the treatment and control groups. An analog
of the multiple linear regression model is the parametric accelerated failure time (AFT)
model where the log-transformed failure times are linear functions of the predictors. In the
following we consider a log-normal AFT model of the uniformity failure times given by
log y˜i(0) = qiβ + σi, where qi = (1, Zi, Gi, ZiGi, Ai) and the errors i are independent and
normally distributed with mean zero and variance one. (For the FBFP causal model, Gi may
8be replaced by Ti.) Following the likelihood ratio principle for testing, a likelihood ratio
permutation test is expected to be the most powerful test against certain alternatives (see
Lehmann and Romano (2005), Chapter 5.9 for an example in the setting where there is no
interference and no censoring). Let D=(D1, . . . , Dn) denote the vector of failure indicators,
and denote the log-likelihood by:
l(Z,D;β, σ, θ0) =
n∑
i=1
[Di log {φ(i)/(σy˜i(0))}+ (1−Di) log {1− Φ(i)}] , (3)
where i = {log y˜i(0)− qiβ} /σ, and φ and Φ are the standard normal density and dis-
tribution functions respectively; see for example, Equation (6.25) of Collett (2003). Let
βˆ and σˆ denote the maximum likelihood estimates (MLEs), and let β˜ and σ˜ denote the
MLEs for the ‘intercept-only’ model, i.e., under the restriction β = (1, 0, 0, 0, 0)T . Then the
log-likelihood difference is LRaft(Z,D; θ0) = l(Z,D; βˆ, σˆ, θ0) − l(Z,D; β˜, σ˜, θ0). In practice,
l(Z,D; βˆ, σˆ, θ0) can be used in place of LRaft(Z,D; θ0) since l(Z,D; β˜, σ˜, θ0) is constant with
respect to Z for a fixed value θ0. Note the AFT model should only be considered as a ‘working
model,’ used solely to generate a test statistic for a hypothesis testing procedure. Under the
randomization-based framework, valid inference does not rely on this working model being
correctly specified. Rather, l(Z,D; βˆ, σˆ, θ0) can simply be viewed as a mathematical (scalar)
summary of {y(0),D,Z} that is compared against other treatment assignments for assessing
the plausibility of H0 : θ = θ0.
3.2 Correcting for right censored uniformity trial failure times
The randomization-based inferential procedures described in Section 2.3 do not necessarily
yield tests that preserve the nominal size in the presence of right censoring, even if the test
statistics considered in Section 3.1 are utilized. Randomization tests of no treatment effect on
the failure times in the presence of censoring generally only preserve the nominal size when
treatment does not affect the censoring times. To see this, consider for a moment the setting
where there is no interference between individuals, so that each individual has two potential
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failure time outcomes y˜i(0) and y˜i(1), and two potential censoring times ci(0) and ci(1).
Let Y˜i = y˜i(Zi) and Ci = ci(Zi), and define Yi and Di as above. Consider testing the null
hypothesis of no individual-level treatment effect, i.e., H0 : y˜i(0) = y˜i(1) for i = 1, . . . , n,
using some test statistic which is a function of {Y,D,Z} where Y = (Y1, . . . , Yn) is the
vector of observed outcomes. If we assume ci(0) = ci(1), then under the null both Yi and Di
will be the same regardless of treatment, allowing exact determination of the test statistic’s
sampling distribution by enumeration over all possible re-assignments in Ω.
However, when inverting a randomization test to construct a confidence set, null hypotheses
corresponding to non-zero treatment effects on the failure times must also be tested. For such
null hypotheses, the standard randomization testing approach described in Section 2.3 cannot
be used to determine a test statistic’s sampling distribution under the null, because in general
an individual’s censoring indicator Di will not be fixed over all possible re-assignments z ∈ Ω,
even if treatment has no effect on the censoring times. To see this, returning to the setting
where there is interference consider the causal model Fadd and suppose Zi = 1 and Di = 0,
i.e., individual i is assigned treatment and is censored at time Yi with failure time Y˜i > Yi.
Further assume treatment has no effect on the censoring times, so that the potential censoring
time for individual i equals Yi for all treatments z ∈ Ω. Now consider testing H0 : θ = θ0
where δ0 > log(Y˜i/Yi) and τ0 = 0. Then for treatment re-assignment z
′ ∈ Ω where z′i = 0 it
follows that y˜i(z
′) = y˜i(0) = Y˜i exp (−δ0) < Yi, i.e., individual i would not be censored for
treatment z′. Thus, as will be demonstrated empirically in Section 3.3 below, a randomization
test that holds the set of censored individuals fixed over treatment re-assignments will not
in general control the type I error. Instead, we propose the following randomization-based
inferential procedure that allows the set of censored individuals to vary over re-assignments.
The procedure entails adapting the IPZ permutation test by Wang et al. (2010). An outline
of the procedure is as follows. First, y(0) is determined under H0 using the specified causal
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model F and a test statistic from Section 3.1 is evaluated at {y(0),D,Z}. Second, the sam-
pling distribution of the test statistic under H0 over hypothetical treatment re-assignments
is approximated by: (i) imputing the unknown uniformity trial failure times for censored
individuals according to the assumed causal model F under H0, and (ii) non-parametrically
imputing censoring times using treatment group-specific Kaplan-Meier estimators of the
censoring time distributions. No causal model is assumed for the censoring times.
The specific procedure is as follows. For a single observed dataset {Y,D,Z}, the following
steps are carried out to test H0 : (δ, τ) = (δ0, τ0):
1. Determine the possibly right censored uniformity trial potential failure times under H0,
e.g., under the causal model Fadd, yi(0) = Yi exp {− (δ0Zi + τ0Gi)}. Calculate the ob-
served value of the chosen test statistic, e.g., the log-rank statistic, using {y(0),D,Z}.
(a) Compute the Kaplan-Meier (KM) estimator of the distribution function of the uni-
formity failure times under H0 using {y(0),D}. Denote the estimator by Fˆ0(·).
(b) For z = 0, 1, among individuals with treatment Zi = z, compute the group-specific
KM estimator of the censoring time distribution, using the observed times Yi and
censoring indicators 1−Di. Denote the estimators by Sˆ(·|z).
2. Randomly sample a new treatment assignment z ∈ Ω.
3. If Di = 1, set y˜
∗
i (0) = yi(0), where yi(0) = y˜i(0) is the observed uniformity failure time un-
der H0. Otherwise if Di = 0, since y˜i(0) is unknown, sample a failure time from a truncated
distribution with lower bound yi(0) as follows. Randomly draw u ∼ Uniform[Fˆ0(yi(0)), 1].
If u 6 Fˆ0(y˜max(0)), where y˜max(0) = maxi:Di=1 y˜i(0) is the maximum observed uniformity
failure time, set the failure time as y˜∗i (0) = Fˆ
−1
0 (u); otherwise set y˜
∗
i (0) = y˜max(0). (The ∗
symbol distinguishes the imputed failure times from the unknown failure times y˜i(0) for
those with Di = 0.) Determine the potential failure times under treatment z using the
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assumed causal model and the null parameter values, e.g., y˜i(z) = y˜
∗
i (0) exp(δ0zi + τ0gi),
where gi is the realization of Gi under treatment z.
4. Sample a censoring time under treatment assignment z, denoted by ci(z), from Sˆ(·|zi)
as follows. Randomly draw v ∼ Uniform(0, 1). Let Ymax = maxi:Zi=zi Yi be the maximum
observed time among individuals with treatment Zi = zi. If Ymax is a censoring time, then
the KM estimator of the censoring time distribution evaluated at Ymax is Sˆ(Ymax|zi) = 1.
Hence set the censoring time to be ci(z) = Sˆ
−1(v|zi). Otherwise if Ymax is a failure time
so that Sˆ(Ymax|zi) < 1, set the censoring time to be ci(z) = Sˆ−1(v|zi) if v 6 Sˆ(Ymax|zi)
and let ci(z) = Ymax otherwise. Hence ci(z) 6 Ymax so that any imputed potential failure
time longer than Ymax will be censored at Ymax.
5. Determine the potential outcomes under treatment z as yi(z) = min{y˜i(z), ci(z)} and the
failure indicators as di(z) = 1 if y˜i(z) 6 ci(z) or 0 otherwise.
6. Determine the uniformity outcomes under treatment z using the same causal model as
in step 1, e.g., y†i (0) = yi(z) exp {− (δ0zi + τ0gi)}. (The † symbol denotes the uniformity
outcomes determined using yi(z), which differ from the uniformity outcomes determined
using Yi in step 1.) Compute the chosen test statistic using {y†(0),d(z), z}, where y†(0) =(
y†1(0), . . . , y
†
n(0)
)
and d(z) = (d1(z), . . . , dn(z)) are vectors of length n.
7. The sampling distribution of the chosen test statistic can be obtained by repeating steps
2 to 6. The p-value for testing H0 can be determined by comparing the resulting sampling
distribution with the observed value of the chosen test statistic from step 1.
3.3 Empirical evaluation of proposed tests
In this section, the ability of the proposed procedure to better control the type I error
in the presence of right censoring is assessed empirically. A simulation study is conducted
as follows. The total number of individuals n is set to 128, with exactly m individuals
assigned to treatment as in a completely randomized experiment. For each individual i, the
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interference set Ai is generated once as follows: (i) randomly draw the interference set size
as Ai ∼ Poisson(16); (ii) sample without replacement Ai values of j ∈ {1, . . . , n} \ i and set
Aij = 1 for the sampled values of j; then (iii) set the remaining values of Aij to 0.
Step 0. Sample the uniformity failure times as log y˜i(0) ∼ N (µ, σ2), where (µ, σ2) = (4.5, 0.252).
Step 1. Randomly draw an observed treatment assignment Z from Ω. Determine the failure
time for individual i with observed treatment (Zi, Gi) by Y˜i= y˜i(0) exp
(
δ†Zi+τ †Gi
)
for (δ†, τ †) = (0.7, 2.8). The values of (δ†, τ †) are chosen so that for Gi > 0.25, the
magnitude of the spillover effect is greater than the direct effect, i.e., τ †Gi > δ†. The
censoring times are then drawn from distributions that depend on treatment. First
the dropout times C˜i are randomly drawn from a lognormal distribution log C˜i ∼
N (µ+ τ †Gi, ω2), where ω2 = 1− 0.252. The administrative censoring time is defined
as C ′i = exp(µ + 2σ + τ
†). If Zi = 1, set the censoring time to Ci = min{C ′i, C˜i};
otherwise, assume there is no dropout and Ci = kC
′
i for some specified proportion
k. Determine the observed outcomes Yi and failure indictors Di as defined above.
Step 2. Under H0 : (δ0, τ0) = (0.7, 2.8), determine yi(0) = Yi exp {− (δ0Zi + τ0Gi)}. For the
dataset {y(0),D,Z}, carry out the LogR and LRaft tests, either holding D fixed over
re-assignments, or using the proposed method in Section 3.2. The p-values pvC(δ0, τ0)
are calculated with C = 10000.
Step 0 was carried out once, then steps 1 and 2 repeated 2000 times each for k = 1,m = 124.
The empirical cumulative distribution functions (ECDFs) of the LogR and LRaft p-values
holding D fixed over re-assignments are plotted in the left panel of Figure 1. Neither test
controlled the nominal type I error rate in general, with both ECDFs above the diagonal
indicating inflated rejection rates of H0 above the nominal size. While the empirical type I
error rate of the LogR test was below the nominal rate at certain significance levels, this is
not guaranteed to be the case in general.
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[Figure 1 about here.]
The empirical results using the proposed method in Section 3.2 are shown in the right panel
of Figure 1. The LogR and LRaft tests both had type I error rates that approximately equal
the nominal size for all significance levels α, with both ECDFs lying approximately on the
diagonal. Similar results for other values of k and m are shown in Web Figures 5 and 6. The
proposed method was further evaluated using a different (symmetric) interference structure
that was generated as a linear preferential attachment network following Jagadeesan et al.
(2017). Settings where the uniformity failure times were correlated between individuals
and were correlated with censoring times were also considered. Details of these studies
(32 different simulation settings) are given in Web Appendix A. The results, displayed in
Web Figures 5 to 12, demonstrate that the proposed method controlled the type I error at
approximately the nominal level over a variety of scenarios.
Additional simulation studies were conducted to compare the power of the LRaft and LogR
tests. Details of these studies are described in Web Appendix B. The results displayed in
Figure 2 correspond to testing the null hypotheses H0 : (δ0, τ0) = (0.6, 2.8) (left panel) and
H0 : (δ0, τ0) = (0.7, 3.2) (right panel) when the true data generating parameter values were
(δ, τ) = (0.7, 2.8). Power using the LRaft and LogR tests was similar for (δ0, τ0) = (0.6, 2.8),
whereas for (δ0, τ0) = (0.7, 3.2) the LRaft test was more powerful with LogR having power
approximately equal to the nominal significance level. The observed lack of power of LogR
to detect spillover effects different from that posited under the null aligns with intuition
since this statistic only compares (censored) uniformity trial outcomes between treated and
untreated individuals, with no attempt to account for the proportion (or number) of treated
neighbors. Results for other assumed values of (δ0, τ0), as well as empirical coverage of the
LRaft and LogR 95% confidence sets, are provided in Web Appendix B.
In summary, results from these simulation studies indicate the randomization test proce-
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dure in Section 3.2 controls the type I error (empirically) over a range of settings, and the
LRaft test tends to be as or more powerful than the LogR test. Moreover, the LogR test can
lack power to detect spillover effects and thus is not recommended in practice when assuming
the additive causal model.
[Figure 2 about here.]
4. Application to randomized trial of cholera vaccine
In this section the methods described above are utilized to assess the effects of cholera
vaccination in a placebo-controlled individually-randomized trial in Matlab, Bangladesh (Ali
et al., 2005). In prior analyses of these data, Ali et al. (2005) found a negative association
between an individual’s risk of cholera infection and the proportion of individuals vaccinated
in the area surrounding an individual’s residence, suggesting possible interference. Similarly,
analysis by Emch et al. (2009) found that the risk of cholera was inversely related with
vaccine coverage in environmental networks that were connected via shared ponds. Likewise,
Root et al. (2011) concluded that the risk of cholera among placebo recipients was inversely
associated with level of vaccine coverage in their social networks. Motivated by these associ-
ation analyses, Perez-Heydrich et al. (2014) used inverse probability weighted estimators to
provide evidence of a significant indirect (spillover) effect of cholera vaccination. However,
Perez-Heydrich et al. assumed partial interference based on a spatial clustering of individuals
into groups and did not account for right censoring. Misspecification of the interference
structure and failure to account for right censoring may bias results. The analysis below
considers other possible interference structures and allows for right censoring.
All children aged 2-15 years and females over 15 years in the Matlab research site of the
International Centre for Diarrheal Disease Research, Bangladesh were individually assigned
randomly to one of three possible treatments: B subunit-killed whole cell oral cholera vaccine;
killed whole cell-only oral cholera vaccine; or Escherichia coli K12 placebo. Recipients of
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either vaccine were grouped together for analysis as the vaccines were identical in cellular
composition and similar in protective efficacy in previous analyses. Denote Z = 0 for those
assigned to placebo, and Z = 1 for those assigned to either vaccine. Individuals were only
included in the analysis if they had completely ingested an initial dose and had completely
or almost completely ingested at least one additional dose. There were a total of n = 72965
individuals in the randomized trial subpopulation for analysis, with m = 48660 assigned to
vaccine and n−m = 24305 to placebo. The primary outcome for analysis was the (failure)
time in days from the 14th day after the vaccination regimen was completed (end of the
immunogenic window; Clemens et al. 1988), until a patient was diagnosed with cholera
following presentation for treatment of diarrhea. Failure times for many trial participants
were right censored either due to outmigration from the field trial area or death prior to the
end of the study, or administrative censoring at the end of the study on June 1, 1986.
4.1 Interference specifications
The vaccine trial is analyzed using one of three different specifications of interference in
turn. Person-to-person transmission of cholera often takes place within the same bari, i.e.,
geographically clustered households of patrilineally-related individuals. Therefore, for all
three specifications, an individual’s interference set includes all other individuals residing in
the same bari. In other words, all individuals i, j residing in the same bari have Aij = 1.
There are 6423 geographically discrete baris with each individual residing in exactly one
bari. Three different specifications are posited regarding how an individual’s interference set
may also include individuals in different baris.
The first specification follows the same approach in Perez-Heydrich et al. (2014). Baris
are partitioned into ‘neighborhoods’ according to a single linkage agglomerative clustering
method. No interference is assumed between individuals in different neighborhoods and no
additional assumptions are imposed regarding the interference structure. That is, partial
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interference is assumed under this specification. The average number of individuals in each
interference set is 419 with an interquartile range (IQR) of 120–631.
Ali et al. (2005) found an association between the cholera risk for a placebo recipient
and the vaccine coverage among individuals living within a 500 meter (m) radius of the
placebo recipient. Following Ali et al., the second specification of the individual interference
sets assumes an individual’s potential outcomes may possibly depend on those living in
a different bari within a 500m radius of the bari s/he resided in. This specification does
not assume partial interference. The average number of individuals in each interference set
under this specification is 499 (IQR 339–626). Baris in the same neighborhood under the first
specification may be more than 500m apart, e.g., in sparsely populated regions; conversely,
baris in different (possibly adjacent) neighborhoods may be less than 500m apart. Hence,
Aij =1 under either specification does not imply that Aij =1 under the other specification.
The previous two specifications assume a local interference structure based on geographical
location of individuals’ households. Following Root et al. (2011), the third interference
structure is defined according to a kinship-based social network between baris. The Matlab
Demographic Surveillance System recorded the exact dates and bari of residence over time
for each individual. An individual who migrated between two baris, primarily due to kinship
relationships such as marriage, created a non-directional social tie between the baris. The
average number of individuals in each interference set under this specification is 162 (IQR
70–225). Submatrices of the interference matrices for 500 selected participants under each of
the three specifications (‘Neighborhood,’ ‘500m,’ and ‘Social’) are depicted in Figure 3. The
interference matrices for all n = 72965 participants are shown in Web Figure 15.
[Figure 3 about here.]
The study population also included 44887 individuals who did not participate in the
randomized trial, and thus have zero probability of receiving either cholera vaccine. However,
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most of these individuals also resided in the same baris as those who took part in the
trial: 5661 baris contained a mixture of participants and non-participants, with a median
participation rate of 71% within a bari. Since the three specified interference sets are defined
based on baris, the definition of Gi is expanded to include non-trial participants as follows.
Let Bi be the total number in the study population, regardless of trial participation, who
may possibly interfere with person i, so that Bi > Ai > Ti. Denote the proportion of Bi who
receive treatment as G∗i , i.e., G
∗
i = Ti/Bi.
4.2 Results
For each specified interference matrix, confidence sets for (δ, τ) were constructed under the
causal model Yi = yi(0) exp(δZi+τG
∗
i ) by conducting hypothesis tests over a discrete grid of
values of (δ0, τ0). It was not computationally feasible to enumerate Ω exactly with
(
72965
48660
) ≈
1020162 possible re-assignments, so p-values were calculated with C = 4000 random draws
from Ω. The LRaft 95% confidence sets are plotted in Figure 4, with the contours indicating
(δ0, τ0) values yielding the same p-values. The boundaries of the 95% confidence set are
demarcated by the contour lines that indicate p-values at least as large as 0.05.
[Figure 4 about here.]
There is evidence vaccination has an effect on the risk of cholera as the 95% confidence
sets exclude (δ, τ) = (0, 0) under all three interference specifications. Point estimates of
the joint treatment effects, corresponding to values of (δ0, τ0) with the largest p-value, are
positive, suggesting the effect of the vaccine in reducing the risk of cholera is a combination of
protective direct and spillover effects. The direct effect estimates are similar across the three
interference specifications, whereas the spillover effect estimate is somewhat higher for the
Social interference specification. For the 500m interference structure, the estimated treatment
effect is (δˆ, τˆ) = (0.7, 4.0). We offer two interpretations of (δˆ, τˆ) under the additive causal
model. First, the average time until cholera diagnosis had everyone not received vaccine (i.e.,
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the uniformity trial) is estimated to be exp(0.7 + 4.0) = exp(4.7) ≈ 110 times faster than if
everyone had received vaccine (e.g., the ‘blanket coverage’ trial). Second, the estimated risk
of cholera incidence at 365 days under the uniformity trial would be approximately 2.30%
compared to 0.06% under the blanket coverage trial, corresponding to a 98% reduction.
The individual parameter estimates also have a straightforward interpretation. For example,
holding the proportion of neighbors treated fixed, exp(δˆ) = exp(0.7) ≈ 2 is the estimated
ratio of survival times when an individual receives treatment versus control. Similarly, holding
individual treatment fixed, exp(τˆ) = exp(4.0) ≈ 55 is the estimated ratio of survival times
when all neighbors are treated compared to no neighbors being treated.
The BFP model was considered unrealistic a priori for this example because there was
no plausible scientific rationale for limiting the spillover effect to those who do not receive
the vaccine, and to be strictly smaller in magnitude than the direct effect. Nonetheless, for
completeness, inference was carried out for parameters under an assumed BFP model. No
p-values were above 0.05, suggesting that the BFP model is a poor fit to the data.
5. Discussion
In this paper we proposed randomization-based methods for assessing the effect of treatment
on right-censored outcomes in the presence of general interference. There are several avenues
of possible future related research. The adapted IPZ procedure as implemented only allows
for unequal censoring based on Z. A proportional hazards model may be used in place
of the group-specific KM estimators to allow for censoring to differ based on Z and G.
Building on the empirical results in this paper, future research could examine theoretical
properties of the proposed procedures, e.g., determine conditions under which type I error
rate control is guaranteed. Joint parametric causal models for both the failure times and
censoring times in the presence of general interference might also be considered. Since
inference is contingent on the choice of interference structure assumed, possible extensions
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include developing sensitivity analysis methods for assessing robustness to interference struc-
ture misspecification. Alternatively, extensions of randomization-based inference approaches
that do not require a parametric causal model, such as Sa¨vje et al. (2017), to the setting
where outcomes are censored could be considered. Methods such as Athey et al. (2018) and
Jagadeesan et al. (2017) that use restricted randomizations to improve statistical power and
computational speed might also be considered. While illustrated in this paper using data
from an individually-randomized trial, the proposed methods can be employed in cluster-
randomized trials. Finally, although this paper has focused on two specific causal models,
the proposed methods are general and easily extended to other causal models.
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Web Appendices
A. Additional type I error simulation results
The simulation study in Section 3.3 was repeated for all combinations of k = 0.6, 1 and
m = 124, 96, 64, 32. The empirical cumulative distribution functions (ECDFs) of the LogR
and LRaft p-values are plotted in Figures 5 (k = 0.6) and 6 (k = 1). The failure rates were
between 11% and 24% in the Z = 1 arm, and between 59% and 100% in the Z = 0 arm.
[Figure 5 about here.]
[Figure 6 about here.]
The simulation study was also carried out using a (symmetric) interference structure that
was generated as a linear preferential attachment (PA) network following Section 9.2 of
Jagadeesan et al. (2017). The network is constructed by starting with a single individual
and then adding one new individual at a time until there are n individuals in the network.
Each new individual that is added, denoted by e.g., j, forms an edge with each of the existing
individuals i = 1, . . . , j − 1 with a probability that is proportional to Ai; for j > m, each
new individual j that is added forms m new edges. The network can be generated using the
sample pa function in the igraph package (Csardi and Nepusz, 2006). As in the simulation
study in Section 3.3, the average number of neighbors is about 16; however, there are now
individuals with comparatively large number of neighbors e.g., about 70. This simulation
study was then carried out for all combinations of k = 0.6, 1 and m = 124, 96, 64, 32. Plots of
the ECDFs of the p-values are shown in Figures 7 (k = 0.6) and 8 (k = 1). The failure rates
were between 11% and 24% in the Z = 1 arm, and between 58% and 100% in the Z = 0
arm.
[Figure 7 about here.]
[Figure 8 about here.]
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The simulation study was further carried out with uniformity trial failure times that are
correlated between individuals, and with the censoring times. The uniformity failure times
y˜i(0) and the dropout times C˜i are generated in Step 0 and 1 respectively as follows:
(0) Determine the n × n correlation matrix ρ as follows. For i, j = 1, . . . , n, i 6= j, let A˜ij =
Aij/Ai×Uij, where Uij ∼ Uniform(0.9, 1). Set ρii = 1, i = 1, . . . , n, and ρij =
(
A˜ij + A˜ji
)
, i, j =
1, . . . , n, i 6= j. (The sum A˜ij+A˜ji ensures symmetry in ρ, while the random jitter Uij ensures
that ρ is positive definite.) Sample the vector of n log-transformed uniformity failure times,
denoted by u = (u1, . . . , un), from the multivariate normal distribution with mean vector
µ1n, where 1n is the vector of n ones, and covariance matrix σ
2ρ; i.e., u ∼ Nn(µ1n, σ2ρ). Let
µ = 4.5 and σ2 = 0.252. Set the uniformity failure time for individual i as y˜i(0) = exp(ui).
(1) For an observed treatment assignment, sample the vector of n log-transformed dropout
times, denoted by R = (R1, . . . , Rn), from the multivariate normal distribution with mean
vector µ1n + τ
†G, where G = (G1, . . . , Gn), and covariance matrix ω2ρ; i.e., R ∼ Nn(µ1n +
τ †G, ω2ρ). Let τ † = 2.8 and ω2 = 1− 0.252. Determine the dropout times as C˜i = exp(Ri).
All 16 combinations of k = 0.6, 1, m = 124, 96, 64, 32 and the interference structure in
Section 3.3 and the linear preferential attachment network are considered. Plots of the ECDFs
of the p-values are shown in Figures 9 to 12. The failure rates were between 11% and 24%
in the Z = 1 arm, and between 58% and 99% in the Z = 0 arm.
[Figure 9 about here.]
[Figure 10 about here.]
[Figure 11 about here.]
[Figure 12 about here.]
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B. Simulation study of statistical power
To compare the power of the LRaft and LogR tests under the proposed method in Section 3.2,
the simulation study in Section 3.3 was repeated as follows. For each simulated dataset with
k = 1 and m = 96, the p-values pvC(δ0, τ0) with C = 2500 were calculated for a discrete grid
of values (δ0, τ0) ∈ {0.4, 0.5,. . ., 1.0}×{0.8, 1.2. . ., 4.0} in step 2. Plots of the ECDFs of the
p-values for selected values of (δ0, τ0) are shown in Web Figure 13. 95% confidence sets for
(δ, τ) were then constructed for each simulated dataset. The proportion of LRaft and LogR
95% confidence sets that included each value of (δ0, τ0) tested are plotted in Web Figure 14.
Both the LRaft and LogR confidence sets included the true value of (δ, τ) = (0.7, 2.8) at the
nominal coverage level. The LRaft confidence sets tended to exclude other values of (δ, τ),
except when (δ0, τ0) were close to the true values (δ, τ) = (0.7, 2.8). On the other hand,
the LogR confidence sets tended to include, at the nominal coverage level, values of (δ0, τ0)
whenever δ0 was close to the true value of δ = 0.7, even for assumed values of τ0 which
were not close to the true value of τ = 2.8. These results are in concert with those in Web
Figure 13 which show the LogR test lacks power to detect indirect (spillover) effects which
are different from those specified under the null.
[Figure 13 about here.]
[Figure 14 about here.]
C. Availability of R code
The R code used to implement the proposed methods and to carry out the simulation studies
in Section 3.3 and in Web Appendices A and B of this document are available at the following
web address: https://github.com/wwloh/General-Interference-Censoring
[Figure 15 about here.]
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Figure 1. Empirical cumulative distributions of p-values for the different test procedures
described in Section 3.2. For the procedure corresponding to the left panel, the failure indica-
tors Di are held fixed over re-assignments. In contrast, the proposed method corresponding
to the right panel allows for the set of censored individuals to vary over re-assignments.
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Figure 2. Empirical cumulative distributions of p-values from a simulation study de-
scribed in Web Appendix B using the proposed method in Section 3.2. The true parameter
values used to generate the data were (δ, τ) = (0.7, 2.8). The left panel corresponds to
testing the null H0 : (δ0, τ0) = (0.6, 2.8), and the right panel corresponds to testing the null
H0 : (δ0, τ0) = (0.7, 3.2).
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Figure 3. Submatrices of the interference matrices for 500 selected participants in the
randomized cholera vaccine trial, based on Neighborhood (left), 500m (center), and Social
(right) interference specifications.
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Figure 4. LRaft 95% confidence sets for (δ, τ) under the additive model Fadd, and each
specified interference matrix (Neighborhood, 500m or Social) for the cholera data. The
contours indicate values of (δ0, τ0) yielding the same p-values, with darker hues indicating
larger p-values. The boundaries of the 95% confidence set are demarcated by the contour
lines that indicate p-values of at least 0.05. The point estimate (δˆ, τˆ) corresponding to the
highest p-value under each interference structure is indicated by x.
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Figure 5. Empirical cumulative distributions of p-values using the interference structure
described in Section 3.3 and k = 0.6. Each panel corresponds to a different value of m as
stated in the title. The average proportions of observed failures in the Z = 1 and Z = 0
groups are stated in the title as ‘p1’ and ‘p0’ respectively.
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Figure 6. Empirical cumulative distributions of p-values using the interference structure
described in Section 3.3 and k = 1. Each panel corresponds to a different value of m as stated
in the title. The average proportions of observed failures in the Z = 1 and Z = 0 groups are
stated in the title as ‘p1’ and ‘p0’ respectively. The bottom right panel is presented in the
main paper as the right panel in Figure 1.
Randomization inference with general interference and censoring 31
0.0 0.4 0.8
0.
0
0.
4
0.
8
m=32,p1=0.24,p0=1
p
Pr
op
or
tio
n
≤
p
LogR
LRaft
0.0 0.4 0.8
0.
0
0.
4
0.
8
m=96,p1=0.23,p0=0.95
p
Pr
op
or
tio
n
≤
p
LogR
LRaft
0.0 0.4 0.8
0.
0
0.
4
0.
8
m=64,p1=0.24,p0=1
p
Pr
op
or
tio
n
≤
p
LogR
LRaft
0.0 0.4 0.8
0.
0
0.
4
0.
8
m=124,p1=0.11,p0=0.58
p
Pr
op
or
tio
n
≤
p
LogR
LRaft
Figure 7. Empirical cumulative distributions of p-values using the PA interference struc-
ture and k = 0.6. Each panel corresponds to a different value of m as stated in the title. The
average proportions of observed failures in the Z = 1 and Z = 0 groups are stated in the
title as ‘p1’ and ‘p0’ respectively.
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Figure 8. Empirical cumulative distributions of p-values using the PA interference struc-
ture and k = 1. Each panel corresponds to a different value of m as stated in the title. The
average proportions of observed failures in the Z = 1 and Z = 0 groups are stated in the
title as ‘p1’ and ‘p0’ respectively.
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Figure 9. Empirical cumulative distributions of p-values using the interference structure
described in Section 3.3 and k = 0.6, with failure times correlated between individuals and
with censoring times. Each panel corresponds to a different value of m as stated in the title.
The average proportions of observed failures in the Z = 1 and Z = 0 groups are stated in
the title as ‘p1’ and ‘p0’ respectively.
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Figure 10. Empirical cumulative distributions of p-values using the interference structure
described in Section 3.3 and k = 1, with failure times correlated between individuals and
with censoring times. Each panel corresponds to a different value of m as stated in the title.
The average proportions of observed failures in the Z = 1 and Z = 0 groups are stated in
the title as ‘p1’ and ‘p0’ respectively.
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Figure 11. Empirical cumulative distributions of p-values using the PA interference
structure and k = 0.6, with failure times correlated between individuals and with censoring
times. Each panel corresponds to a different value of m as stated in the title. The average
proportions of observed failures in the Z = 1 and Z = 0 groups are stated in the title as ‘p1’
and ‘p0’ respectively.
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Figure 12. Empirical cumulative distributions of p-values using the PA interference
structure and k = 1, with failure times correlated between individuals and with censoring
times. Each panel corresponds to a different value of m as stated in the title. The average
proportions of observed failures in the Z = 1 and Z = 0 groups are stated in the title as ‘p1’
and ‘p0’ respectively.
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Figure 13. Empirical cumulative distributions of p-values from a simulation study using
the proposed method in Section 3.2. The true parameter values used to generate the data
were (δ, τ) = (0.7, 2.8). The assumed values of (δ0, τ0) for testing the null hypothesis are
stated in the title of each panel. The panels corresponding to the null hypotheses H0 :
(δ0, τ0) = (0.6, 2.8) and H0 : (δ0, τ0) = (0.7, 3.2) are presented in the main paper as the left
and right panels respectively in Figure 2.
38
0.1
0.5
0.8
1
2
3
4
0.4 0.6 0.8 1.0
δ
τ
LRaft
0.1
0.1
0.5 0.50.8 0.8
1
2
3
4
0.4 0.6 0.8 1.0
δ
τ
LogR
Figure 14. Average empirical coverage of LRaft (left) and LogR (right) 95% confidence
sets. Each value of (δ0, τ0) tested is indicated by a square, with the empirical coverage
determined by the proportion of 95% confidence sets that included each pair of (δ0, τ0). The
contours are labelled with the coverage levels, with filled squares indicating coverage of at
least 0.95. The true parameter values used to generate the data were (δ, τ) = (0.7, 2.8).
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Figure 15. Interference matrices for all n = 72965 participants in the randomized cholera
vaccine trial, based on Neighborhood (left), 500m (center), and Social (right) interference
specifications.
